supplementNot FDA-approvedOTC supplementSublingual NAD+/NMN products are sold as dietary supplements in the US and are not FDA-approved drugsThe cited comparison study evaluated NMN, a direct NAD+ precursor, rather than intact NAD+ molecule delivered sublingually
NAD+ SublingualBenefits, Dosage & Interactions
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in all living cells, playing a crucial role in metabolism and various cellular processes. It is essential for energy production, DNA repair, and gene expression, influencing many aspects of health and aging.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Moderate — One published human randomized trial; results not yet replicated.
Evidence strengthModerate · 3/4
PreclinicalStrong human evidence
One published human randomized trial; results not yet replicated.
Plasma half-life
Not applicable
Typical timing
morning
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- The cited crossover pharmacokinetic study compared sublingual and oral NMN doses in the range used in the referenced human NMN trials, roughly 250–900 mg per day in the placebo-controlled dose-ranging trial[1][2][3]
- Route studied
- Sublingual, compared directly against oral administration in the same crossover cohort[1][2][3]
Reported for NAD+ Sublingual in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the NAD+ Sublingual entry is written from. Each number matches an inline marker above.
- [1]Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult menScientific Reports · 2026 · Peer-reviewed · PMID 42304075
- [2]The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trialGeroScience · 2023 · Peer-reviewed · PMID 36482258
- [3]Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and womenScientific Reports · 2022 · Peer-reviewed · PMID 36002548
How to track NAD+ Sublingual doses
Tracking NAD+ Sublingual well takes four fields and a habit. Here is what to record so the log is still useful in three months.
- 1
Add the dose and unit
Log NAD+ Sublingual with its dose in mg so totals stay comparable over time — including days when you split the dose or skip it.
- 2
Set the time of day and food rule
Typical timing is morning. Reminders fire at that time and can export to your calendar.
- 3
Check it against the rest of the stack
Run NAD+ Sublingual through the interaction checker against everything else in the routine — supplements, peptides, hormones and prescriptions — before it becomes a daily habit.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
Review NAD+ Sublingual alongside your logged metrics and any relevant blood work every few weeks before changing the dose, so the change is a response to data rather than to a good or bad day.
What to log each time
- Dose in mg
- Time of day
- Taken / skipped / delayed
- Any side effects or notable changes
What is NAD+ Sublingual studied for?
What is NAD+ Sublingual?
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in all living cells, playing a crucial role in metabolism and various cellular processes. It is essential for energy production, DNA repair, and gene expression, influencing many aspects of health and aging. As we age, NAD+ levels naturally decline, which has led to significant interest in strategies to boost NAD+ levels to mitigate age-related health issues.
NAD+ sublingual refers to formulations designed for absorption under the tongue, bypassing the digestive system and potentially offering enhanced bioavailability compared to oral forms that are swallowed. This route of administration is thought to allow for direct entry into the bloodstream. NAD+ itself is a relatively large molecule, and its direct bioavailability when taken orally can be limited due to degradation in the digestive tract. Therefore, sublingual delivery aims to address this challenge by providing a more direct route to systemic circulation.
Research into NAD+ and its precursors (such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN)) is ongoing, with studies exploring its potential impact on cellular health, metabolic function, and longevity. While NAD+ is naturally present in the body, supplementation with NAD+ or its precursors is a subject of active scientific investigation.
What does the research say about NAD+ Sublingual?
Tap a section to expand.
NAD+ functions as a vital coenzyme in two primary metabolic pathways: catabolic reactions, where it accepts electrons to become NADH and generate ATP (energy), and anabolic reactions, where it donates electrons. Specifically, NAD+ is a key player in the electron transport chain, a series of reactions that generate cellular energy in the form of adenosine triphosphate (ATP).
Beyond energy metabolism, NAD+ is a critical substrate for several enzyme families, including sirtuins and poly(ADP-ribose) polymerases (PARPs). Sirtuins are a family of NAD+-dependent deacetylases that regulate cellular processes such as DNA repair, inflammation, and cellular stress resistance. By consuming NAD+, sirtuins help maintain genomic stability and regulate metabolic pathways, which are processes often implicated in aging.
PARPs are another group of NAD+-dependent enzymes primarily involved in DNA repair and genomic integrity. When DNA damage occurs, PARPs are activated and consume NAD+ to facilitate repair mechanisms. This consumption of NAD+ can lead to a localized depletion of the coenzyme, impacting other NAD+-dependent processes. The interaction between NAD+ levels, sirtuin activity, and PARP function highlights the central role of NAD+ in maintaining cellular health and responding to stress.
Sublingual administration is hypothesized to enhance the absorption of NAD+ by allowing it to directly enter the bloodstream through the mucous membranes under the tongue, bypassing first-pass metabolism in the liver and degradation in the gastrointestinal tract often associated with orally ingested forms. This direct absorption may lead to higher systemic concentrations of NAD+ compared to swallowed oral supplements, though more direct comparative studies are needed to fully establish the differential bioavailability of NAD+ via sublingual versus other routes.
The potential benefits of maintaining optimal NAD+ levels and the specific effects of sublingual NAD+ supplementation are areas of active research. The proposed benefits generally stem from NAD+'s fundamental roles in cellular energy metabolism, DNA repair, and the regulation of sirtuin activity. These roles are essential for maintaining cellular function and resilience, particularly as the body ages.
One area of interest is **cellular energy production**. NAD+ is critical for the function of mitochondria, the 'powerhouses' of the cell, where it helps convert nutrients into energy. Maintaining adequate NAD+ levels may support efficient cellular energy production, which is foundational for overall cellular health and function across all tissues and organs.
Another significant area is **DNA repair and genomic stability**. NAD+ is a substrate for PARPs, enzymes vital for repairing DNA damage. By supporting these repair mechanisms, NAD+ may contribute to the maintenance of genomic integrity, which is important for healthy cell function and may help mitigate the accumulation of age-related cellular damage.
Furthermore, NAD+ influences **sirtuin activity**. Sirtuins are a family of enzymes that depend on NAD+ for their function. These enzymes play roles in regulating inflammation, metabolism, and cellular responses to stress. By acting as a co-substrate for sirtuins, NAD+ may indirectly support these diverse cellular protective mechanisms.
Given these roles, researchers are investigating the potential of NAD+ supplementation to support healthy aging and address various age-related declines. While much of the foundational research on NAD+ function is well-established (NIH ODS, PubChem), specific benefits of sublingual NAD+ in human populations are still under rigorous investigation. Many studies on NAD+ elevation utilize its precursors (like NR or NMN), and direct studies on sublingual NAD+ itself are fewer (Examine.com). Potential benefits are extrapolations from the known cellular functions of NAD+ and observed effects in preclinical studies and human trials involving NAD+ precursors.
Current evidence regarding NAD+ focuses heavily on its fundamental biochemical roles and the effects of its precursors (like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN)) on NAD+ levels and health outcomes. Evidence for direct sublingual NAD+ supplementation is emerging, but less extensive than for its precursors.
Preclinical studies, particularly in models of aging and metabolic dysfunction, have demonstrated that increasing NAD+ levels through precursor supplementation can positively influence metabolic health, mitochondrial function, and cellular resilience (Cochrane, NIH ODS). These studies suggest that elevating NAD+ may impact longevity-related pathways.
Human clinical trials with NAD+ precursors like NR and NMN have shown that these compounds can effectively increase NAD+ levels in various tissues. For instance, studies have reported that NR supplementation can increase NAD+ in blood cells and muscle tissue, and some trials have explored its impact on metabolic markers, insulin sensitivity, and physical function (Examine.com). Similarly, NMN has been shown to raise NAD+ levels in humans and is being investigated for its effects on various physiological parameters.
Regarding sublingual NAD+ specifically, the rationale for this delivery method is largely based on pharmacokinetic principles – the idea that bypassing digestion may improve bioavailability. However, direct comparative clinical trials demonstrating superior efficacy or bioavailability of sublingual NAD+ compared to other forms or precursors are less common. Evidence for sublingual forms typically relies on anecdotal reports or smaller preliminary studies. Larger, well-controlled human trials are needed to conclusively establish the efficacy and specific benefits of sublingual NAD+ supplementation in various populations and for different health goals (Examine.com). Most authoritative sources, such as NIH ODS and MedlinePlus, discuss NAD+ in general terms or focus on its precursors when discussing supplementation strategies, underscoring that direct research on sublingual NAD+ is a more recent and less thoroughly investigated area.
Based on current research, direct NAD+ supplementation, especially in sublingual form, is generally considered to have a favorable safety profile. However, as with any compound, individual reactions can vary, and potential side effects, though often mild and infrequent, can occur.
Commonly reported side effects for NAD+ and its precursors (NR, NMN) from studies and user experiences include:
* **Gastrointestinal discomfort:** Some individuals might experience mild stomach upset, nausea, or diarrhea, particularly when first starting supplementation or at higher dosages.
* **Flushing:** While less common with direct NAD+ or its forms compared to niacin (nicotinic acid), some individuals might experience a temporary redness or warming sensation of the skin.
* **Headaches:** Infrequent reports of headaches have been associated with NAD+ precursor supplementation.
Specific side effects related to sublingual administration itself could potentially include minor irritation at the site of absorption if the formulation is not well-tolerated or if a user has particular sensitivities. However, such reports are rare in scientific literature.
Long-term safety data for high doses of NAD+ and its sublingual forms are still being established. Clinical trials involving NAD+ precursors have generally reported good tolerability at studied dosages. Always monitor your body's response and consult a healthcare professional if any unexpected or persistent side effects occur. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
While NAD+ sublingual is generally considered safe, certain precautions and warnings apply. Individuals should exercise caution and consult with a healthcare professional, especially if they have pre-existing medical conditions or are taking other medications.
* **Underlying Medical Conditions:** Individuals with active cancers or a history of cancer should use NAD+ sublingual with caution. While some research suggests NAD+ can support healthy cells, other theories propose that cancer cells, which are often rapidly dividing, might also utilize elevated NAD+ levels for growth. This is a complex and highly debated area, and medical guidance is crucial. Similarly, individuals with liver or kidney disease should consult their clinician before use, as these conditions can affect metabolism and excretion of compounds.
* **Pregnancy and Breastfeeding:** There is insufficient data to definitively establish the safety of NAD+ sublingual supplementation during pregnancy or breastfeeding. Therefore, it is generally recommended to avoid use during these periods unless specifically advised and monitored by a healthcare provider.
* **Surgery:** As with many supplements, it is often advised to discontinue NAD+ sublingual at least two weeks prior to any scheduled surgery to avoid potential interactions with anesthesia or effects on blood clotting, though direct evidence for specific interactions with NAD+ is limited.
* **Individual Variability:** Responses to NAD+ sublingual can vary significantly among individuals. Factors such as age, genetics, existing health status, and lifestyle can influence how one responds to supplementation.
It is critical to follow recommended usage guidelines and not exceed suggested dosages, as the long-term effects of very high NAD+ levels are not fully understood. Always prioritize obtaining advice from a qualified clinician who can review your full health profile. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Official contraindications for NAD+ sublingual are not as extensively defined as for prescription medications due to its status as a supplement and the ongoing nature of research. However, based on the current understanding of NAD+ and its metabolic pathways, certain situations warrant avoidance or significant caution.
Strict contraindications, where **use should be avoided entirely**, generally align with situations where there is insufficient safety data or a theoretical risk that outweighs potential benefits:
* **Allergy or Hypersensitivity:** Individuals with a known allergy or hypersensitivity to NAD+, any of its precursors (like nicotinamide riboside or nicotinamide mononucleotide), or any other ingredients in the sublingual formulation should avoid its use. While rare, allergic reactions are possible with any substance.
* **Active Cancer:** The use of NAD+ sublingual in individuals with active cancer is generally contraindicated due to theoretical concerns that elevated NAD+ levels could potentially fuel tumor growth. This remains an area of intensive research, and until more definitive clinical data are available, caution and avoidance are strongly advised. Patients with cancer should never use NAD+ sublingual without strict medical supervision and advice from an oncologist.
* **Children:** NAD+ sublingual is not recommended for use in children. The safety and efficacy in pediatric populations have not been established through research.
While not absolute contraindications, significant caution and medical consultation are advised for pregnant and breastfeeding women, and individuals with severe kidney or liver dysfunction, as discussed in the warnings section. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Due to the nascent nature of research on direct NAD+ sublingual formulations, comprehensive data on specific drug-supplement interactions is limited. However, based on the understanding of NAD+ metabolism and general principles of supplementation, certain interactions are theoretically possible or warrant caution.
* **Chemotherapy Agents:** Given the theoretical concerns about NAD+'s potential role in cellular proliferation, individuals undergoing chemotherapy should absolutely avoid NAD+ sublingual unless specifically directed by their oncologist. Some chemotherapy drugs target rapidly dividing cells, and any factor that might influence cellular metabolism or growth could potentially interfere with treatment efficacy or safety.
* **Immunosuppressants:** NAD+ plays a role in immune cell function. While this is often viewed as beneficial, in individuals on immunosuppressant medications (e.g., post-transplant patients), any compound modulating immune responses could potentially interfere with the drug's intended action or lead to unintended effects. This requires careful consideration and medical advice.
* **Medications Affecting Liver or Kidney Function:** As these organs are involved in the metabolism and excretion of many substances, individuals taking medications that significantly impact liver or kidney function should consult their clinician. While NAD+ itself is endogenous, supplementing with exogenous forms could theoretically add to the metabolic burden. This is largely a precautionary measure due to general principles of pharmacology.
* **Other Supplements Aimed at Boosting NAD+:** Combining NAD+ sublingual with other NAD+ precursors (like NMN, NR), or compounds purported to boost NAD+ (e.g., resveratrol, pterostilbene, apigenin) may lead to excessively high NAD+ levels, the long-term effects of which are not fully established. While beneficial effects are associated with *increasing* NAD+ from low levels, it's unclear if there's an optimal ceiling, and higher is not always better. It's generally advisable to use one strategy to increase NAD+ at a time unless directed otherwise by a clinician.
Always disclose all supplements and medications you are taking to your healthcare provider to help identify potential interactions. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Sublingual NAD+ is typically administered in the morning. This timing is often chosen to align with the body's natural circadian rhythm, as NAD+ levels can fluctuate throughout the day, often being higher in the morning. Some theories suggest that supplementing in the morning supports cellular energy production during the active hours of the day.
The sublingual route allows for rapid absorption, so taking it at a consistent time each day can help maintain steady levels. It can be taken either with or without food. Since it bypasses the digestive system, the presence of food is less likely to impact its absorption directly compared to swallowed oral supplements. However, individual tolerance may vary, and some might prefer to take it consistently around meal times for routine or to minimize any potential mild gastrointestinal effects if experienced. Individual needs vary — talk to a licensed clinician.
What interacts with NAD+ Sublingual?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any glp1 + supplement | Note | Category ruleConfidence: theoretical | GLP-1 medications slow stomach emptying, changing how/when oral supplements absorb; rapid weight loss raises the importance of protein and micronutrients.Source pending | Time oral supplements when nausea is lowest; prioritize protein and micronutrients; discuss with your provider. |
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pending | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
Frequently asked questions about NAD+ Sublingual
NAD+ sublingual is a form of nicotinamide adenine dinucleotide (NAD+) designed to be absorbed under the tongue. This delivery method aims to bypass the digestive system and liver metabolism, potentially allowing for more direct entry into the bloodstream and enhanced bioavailability compared to swallowed oral supplements.
People take NAD+ sublingual to potentially boost their cellular NAD+ levels, which naturally decline with age. The goal is to support various cellular functions including energy production, DNA repair, and the activity of sirtuin enzymes, which are implicated in healthy aging and metabolic processes.
The sublingual route is theorized to offer improved absorption by allowing direct entry into the bloodstream. While this bypasses first-pass metabolism, research into the comparative efficacy and bioavailability of sublingual NAD+ versus other forms (like NAD+ precursors such as NMN or NR, or intravenous NAD+) is still evolving. More direct comparative studies are needed to definitively conclude if one form is superior to another for specific outcomes.
NAD+ sublingual is generally well-tolerated. Potential side effects are usually mild and may include minor gastrointestinal upset (nausea, diarrhea), flushing, or headaches. As with any supplement, individual reactions can vary. It's important to discontinue use and consult a clinician if you experience any adverse effects.
NAD+ Sublingual's crucial to consult with your licensed clinician before combining NAD+ sublingual with any other medications or supplements. While direct interaction data is limited, theoretical concerns exist, particularly with chemotherapy agents, immunosuppressants, or medications affecting liver/kidney function. Your clinician can assess potential risks and ensure safe co-administration.
As a supplement, NAD+ Sublingual can overlap with other supplements, prescription medicines, hormones and peptides. Because NAD+ Sublingual is usually taken in the morning, most avoidable conflicts come from what else lands in that same window. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers NAD+ Sublingual with no sign-up.
NAD+ Sublingual is typically taken in the morning. Amounts for this supplement vary by protocol, formulation and individual response, so follow the dose your clinician or the product label specifies.
Whether NAD+ Sublingual fits alongside testosterone replacement therapy depends on the protocol — dose, ester and ancillaries such as HCG or anastrozole — and on current bloodwork. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
"Peptides" is not one category — healing peptides, GLP-1 agonists, growth-hormone secretagogues and melanocortins each behave differently next to NAD+ Sublingual. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for NAD+ Sublingual varies by protocol and formulation, so the label or prescription is what sets it. It is typically taken in the morning. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of NAD+ Sublingual depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For NAD+ Sublingual the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Verify at
Publisher search links for NAD+ Sublingual. These are places to check the information — they are not citations, so they are not numbered.
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- PubChem(publisher search, opens in a new tab)National Center for Biotechnology Information · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on NAD+ Sublingual?
Plain-text summary, safe to quote verbatim:
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in all living cells, playing a crucial role in metabolism and various cellular processes. It is essential for energy production, DNA repair, and gene expression, influencing many aspects of health and aging.
Source: DoseRoutine — https://doseroutine.com/library/nad-sublingual
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). NAD+ Sublingual — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/nad-sublingual
What compounds are similar to NAD+ Sublingual?
Others in the supplement category or studied for the same goals.
Which goals is NAD+ Sublingual used for?
Other compounds studied for the same benefits as NAD+ Sublingual.
Longevity
See all →Continue exploring
See every compound DoseRoutine catalogs for these goals.